Role and mechanism of connective tissue growth factor in diabetic cardiomyopathy
Role and mechanism of connective tissue growth factor in diabetic cardiomyopathy
批准号:
nhmrc : 402559
负责人:
A/Pr Susan Mclennan
金额:
$25.53万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Diabetic cardiomyopathy is a condition where the heart muscle is directly damaged by diabetes. It is being recognised as a prominent cause of both acute and chronic heart failure in diabetes. It is common and occurs in up to 60% of diabetic patients . At present however, no treatments are available to directly treat the cardiomyopathy. This condition can also occur in people with diabetes who have high blood pressure and-or coronary artery disease and may combine with these problems to worsen patient outcomes. We have generated data in experimental diabetes in rodents that strongly implicates a heart growth factor in causing diabetic cardiomyopathy. This protein, called connective tissue growth factor (CTGF), is increased in diabetic cardiomyopathy, and is elevated by high glucose and other factors in diabetes. We have published data showing that CTGF causes tissue scarring like that which occurs in cardiomyopathy, by affecting signals in cells called fibroblasts. It increases the laying down of extracellular matrix (ECM) and also inhibits the degradation of ECM by the proteins that break down matrix, known as the MMPand PAI systems. Such accumulation of ECM is thought to be a major factor leading to abnormal muscle function in cardiomyopathy. We now plan to block CTGF in this diabetic heart model to determine if we can prevent diabetic cardiomyopathy. We have generated two methods to inhibit CTGF in the animal model. Echocardiography (a heart ultrasound test), and molecular analysis of the heart tissue will determine if we can prevent the otherwise adverse functional and structural changes of diabetes in the heart. We will also study our baboon model of diabetes to determine if diabetic cardiomyopathy with increased heart CTGF is present in the primates. Cell culture studies from rat heart fibroblasts and myocytes will determine how CTGF has the effect on cells to cause cardiomyopathy and how we might further prevent this condition developing in diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Exercise Intervention on the Phenome (Metabolism and Predictive Complications) in Well Characterised Prediabetes and New Onset Type 2 Diabetes Cohorts in China and Australia (TheDiabeEx.JointStudy).
-
批准号:nhmrc : 1113612
-
项目类别:Targeted Calls
-
资助金额:$39.1万
-
财政年份:2016
-
负责人:A/Pr Susan Mclennan
-
依托单位:
The Role of the Hepatocyte and EMMPRIN in Liver Injury
-
批准号:nhmrc : 1063515
-
项目类别:Project Grants
-
资助金额:$40.51万
-
财政年份:2014
-
负责人:A/Pr Susan Mclennan
-
依托单位:
Role of Inflammation in Diabetic Cardiomyopathy
-
批准号:nhmrc : 1030376
-
项目类别:Project Grants
-
资助金额:$32.88万
-
财政年份:2012
-
负责人:A/Pr Susan Mclennan
-
依托单位:
Preventing Adverse Effects of Matrix Metalloproteinases in Diabetic Wound Healing
-
批准号:nhmrc : 1009815
-
项目类别:Project Grants
-
资助金额:$25.86万
-
财政年份:2011
-
负责人:A/Pr Susan Mclennan
-
依托单位:
Diabetes exacerbates non-alcoholic steato-hepatitis (NASH)
-
批准号:nhmrc : 632822
-
项目类别:NHMRC Project Grants
-
资助金额:$37.72万
-
财政年份:2010
-
负责人:A/Pr Susan Mclennan
-
依托单位:
THE ROLE OF THE HEPATOCYTE IN EXTRACELLULAR MATRIX INTERACTIONS IN LIVER FIBROGENESIS
-
批准号:nhmrc : 512283
-
项目类别:NHMRC Project Grants
-
资助金额:$36.04万
-
财政年份:2008
-
负责人:A/Pr Susan Mclennan
-
依托单位:
Novel regulators of fat cell differentiation
-
批准号:nhmrc : 457373
-
项目类别:NHMRC Project Grants
-
资助金额:$29.71万
-
财政年份:2007
-
负责人:A/Pr Susan Mclennan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: